IBDEI1V6 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33201,1,3,0)
 ;;=3^Deformitis of Feet,Congenital NEC
 ;;^UTILITY(U,$J,358.3,33201,1,4,0)
 ;;=4^Q66.89
 ;;^UTILITY(U,$J,358.3,33201,2)
 ;;=^5018874
 ;;^UTILITY(U,$J,358.3,33202,0)
 ;;=E11.40^^191^1966^28
 ;;^UTILITY(U,$J,358.3,33202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33202,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,33202,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,33202,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,33203,0)
 ;;=E11.41^^191^1966^25
 ;;^UTILITY(U,$J,358.3,33203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33203,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,33203,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,33203,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,33204,0)
 ;;=E11.42^^191^1966^31
 ;;^UTILITY(U,$J,358.3,33204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33204,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,33204,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,33204,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,33205,0)
 ;;=E11.43^^191^1966^23
 ;;^UTILITY(U,$J,358.3,33205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33205,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,33205,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,33205,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,33206,0)
 ;;=E11.44^^191^1966^21
 ;;^UTILITY(U,$J,358.3,33206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33206,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,33206,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,33206,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,33207,0)
 ;;=E11.49^^191^1966^26
 ;;^UTILITY(U,$J,358.3,33207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33207,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurolog Compl NEC
 ;;^UTILITY(U,$J,358.3,33207,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,33207,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,33208,0)
 ;;=E10.40^^191^1966^11
 ;;^UTILITY(U,$J,358.3,33208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33208,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,33208,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,33208,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,33209,0)
 ;;=E10.41^^191^1966^8
 ;;^UTILITY(U,$J,358.3,33209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33209,1,3,0)
 ;;=3^DM Type 1 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,33209,1,4,0)
 ;;=4^E10.41
 ;;^UTILITY(U,$J,358.3,33209,2)
 ;;=^5002605
 ;;^UTILITY(U,$J,358.3,33210,0)
 ;;=E10.42^^191^1966^14
 ;;^UTILITY(U,$J,358.3,33210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33210,1,3,0)
 ;;=3^DM Type 1 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,33210,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,33210,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,33211,0)
 ;;=E10.43^^191^1966^6
 ;;^UTILITY(U,$J,358.3,33211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33211,1,3,0)
 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,33211,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,33211,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,33212,0)
 ;;=E10.44^^191^1966^4
 ;;^UTILITY(U,$J,358.3,33212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33212,1,3,0)
 ;;=3^DM Type 1 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,33212,1,4,0)
 ;;=4^E10.44
 ;;^UTILITY(U,$J,358.3,33212,2)
 ;;=^5002608
 ;;^UTILITY(U,$J,358.3,33213,0)
 ;;=E10.49^^191^1966^9
 ;;^UTILITY(U,$J,358.3,33213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33213,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neurologic Compl NEC
 ;;^UTILITY(U,$J,358.3,33213,1,4,0)
 ;;=4^E10.49
 ;;^UTILITY(U,$J,358.3,33213,2)
 ;;=^5002609
 ;;^UTILITY(U,$J,358.3,33214,0)
 ;;=E11.621^^191^1966^32
